Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Pfizer
Study ID
NCT05207865
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic migraine.

Key Dates

Start date
Mar 15, 2022
Status verified
Jul 2025
Primary completion
Jul 2, 2024
Completion
Jul 2, 2024

Study Design

Enrollment
441 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Rimegepant
    rimegepant 75 mg ODT daily

Primary Outcome Measure

Number of Participants With On-Treatment Adverse Events (AEs) (Frequency >=5%) According to Intensity [ Time Frame: From start of study treatment (Day 1) up to 7 days after the last dose of study treatment (Up to 25 weeks) ]

Locations (19)

FacilityCityStateZIPSite coordinators
Elite Clinical Studies, LLCPhoenixArizona85018-
Advanced Investigative Medicine, Inc.HawthorneCalifornia90250-
Velocity Clinical Research - North HollywoodNorth HollywoodCalifornia91606-
Chase Medical Research, LLCWaterburyConnecticut06708-
Phoenix Medical Research, LLCMiamiFlorida33165-
The Headache ClinicAlexandriaLouisiana71301-
Boston Clinical TrialsBostonMassachusetts02131-
Michigan Head Pain & Neurological InstituteAnn ArborMichigan48104-
CVS HealthHub - East BrunswickEast BrunswickNew Jersey08816-
CVS HealthHub - LawrencevilleLawrencevilleNew Jersey08648-
CVS HealthHUB - RunnemedeRunnemedeNew Jersey08078-
SPRI Clinical Trials, LLCBrooklynNew York11235-
Velocity Clinical ResearchCincinnatiOhio45242-
OK Clinical Research, LLCEdmondOklahoma73034-
Clinical Research Philadelphia, LLCPhiladelphiaPennsylvania19114-
WR-ClinSearch, LLCChattanoogaTennessee37421-
VIP TrailsSan AntonioTexas78230-
VIP TrialsSan AntonioTexas78230-
Tidewater Integrated Medical ResearchVirginia BeachVirginia23454-

Related coverage on Hipa.ai

Find similar trials in Phoenix, AZ

By condition
By specialty

Related Studies